Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Epstein-Barr Virus Specific Immunotherapy
Locations
2
United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Start Date
April 1, 2009
Primary Completion Date
March 1, 2012
Completion Date
February 1, 2017
Last Updated
June 28, 2023
NCT06980038
NCT06059261
NCT06636734
NCT07340515
NCT07258979
NCT03010150
Lead Sponsor
Dana-Farber Cancer Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions